You searched for Antibody candidate - Page 12 of 69

Expert Advice 14 Dec 2020

How to Hire and Retain Talent in the Biotech Industry

…specific profiles in the market, but as technology evolved candidates also had to evolve and develop new skills.” In addition, the number of qualified candidates for life sciences positions has…

December 14, 2020 - 7 minutesmins - By Clara Rodríguez Fernández

In Depth 18 May 2020

Will Covid-19 Change the Face of Vaccine Development?

…have not always had an easy ride. “Significant investment, in both time and money, is needed to advance a vaccine candidate to market,” Thomas Lingelbach, CEO of French vaccine developer…

May 18, 2020 - 13 minutesmins - By Helen Albert

In Depth 9 Apr 2025

Cystic fibrosis: is the next blockbuster a gene therapy?

…this article, we will explore how gene therapy works, the biotechs progressing their genetic drug candidates, and why it might just be the breakthrough that people with cystic fibrosis have…

April 9, 2025 - 10 minutesmins - By Roohi Mariam Peter

Best in Biotech 14 Mar 2024

7 oncolytic virus companies you should know about

…it has developed an extensive library of isolated and engineered oncolytic vaccinia virus (a poxvirus similar to smallpox) immunotherapeutic product candidates. The oncolytic virus company’s most advanced candidate, Olvi-Vec (olvimulogene…

March 14, 2024 - 8 minutesmins - By Willow Shah-Neville

Best in Biotech 21 Dec 2023

Five companies racing to bring their NASH treatments toward the finish line

…Drug Administration (FDA)-approved treatments for the disease, many NASH companies are currently attempting to bring their candidates toward approval. In this article, we take a look at five of the…

December 21, 2023 - 7 minutesmins - By Willow Shah-Neville

Best in Biotech 15 Aug 2024

10 neuroscience biotech companies you should know about

…focused on developing the first oral treatment with the potential to slow or stop the progression of Alzheimer’s disease. Its candidate is called ALZ-801 and is currently in phase 3…

August 15, 2024 - 12 minutesmins - By Willow Shah-Neville

In Depth 23 Apr 2025

The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval

…exclusive rights to the candidate in the field of multiple sclerosis worldwide and certain other autoimmune diseases outside of China. Biogen did not specify why it had dropped the candidate…

April 23, 2025 - 9 minutesmins - By Willow Shah-Neville

News and Trends 31 Oct 2018

Multiple Myeloma Antibody Therapy Achieves Positive Phase III Results

An antibody therapy for the blood cancer multiple myeloma achieved positive results at Phase III, decreasing the risk of the disease getting worse and patient death by 45% in a…

October 31, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 20 Jul 2023

Mage Biologics created to develop oral antibody therapy for ulcerative colitis

…(PFC) investment for TVM LSI II. Mage Biologics plans to advance to clinical proof of concept a novel, orally administered, humanized monoclonal antibody (mAb) bioengineered for optimal potency and tissue…

July 20, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 12 Jan 2017

Antibody Treatment for Obesity and Type 2 Diabetes enters Phase II

Novartis is initiating Phase II trials with an antibody licensed from German biotech MorphoSys that tackles the obesity and diabetes epidemic. MorphoSys is a billion euro biotech that develops therapeutic…

January 12, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Oct 2022

WuXi Biologics and Toregem BioPharma to develop antibody for adentia treatment

…Takahashi investigated the effects of a monoclonal antibody for USGA-1. His experiments with this antibody revealed that BMP/Wnt signaling was critical for determining the number of teeth in mice, and…

October 12, 2022 - 3 minutesmins - By Jim Cornall

gsk morphosys hand osteoarthritis rheumatoid

News and Trends 19 Apr 2016

GSK goes to phase II with German Antibody for Inflammatory Diseases

GSK has started a phase II trial for inflammatory hand osteoarthritis, with a candidate originally from MorphoSys‘ antibody library. GSK, a big UK Pharma, has announced the start of a…

April 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

How to Hire and Retain Talent in the Biotech Industry

Will Covid-19 Change the Face of Vaccine Development?

Cystic fibrosis: is the next blockbuster a gene therapy?

7 oncolytic virus companies you should know about

Five companies racing to bring their NASH treatments toward the finish line

10 neuroscience biotech companies you should know about

The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval

Multiple Myeloma Antibody Therapy Achieves Positive Phase III Results

Mage Biologics created to develop oral antibody therapy for ulcerative colitis

Antibody Treatment for Obesity and Type 2 Diabetes enters Phase II

WuXi Biologics and Toregem BioPharma to develop antibody for adentia treatment

GSK goes to phase II with German Antibody for Inflammatory Diseases

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!